Exponent Q1 revs before reimbursements up 6.6% to $137.2M, EPS $0.59, raises FY guidance

EXPONENT INC

2024-Q1 EPS reported $0.59 revenue$144,933,000

Total revenues $144.9M (+3.3% YoY); net income $30.1M ($0.59 diluted EPS) vs $29.1M ($0.56).
EBITDA margin improved to 29.2% ($40.1M) from 27.8% ($35.8M); utilization 75%.
Engineering segment (84% of rev) grew 8% in rev before reimbursements; environmental/health (16%) grew 1%.
Q2 2024 guidance: rev before reimbursements flat to low-single-digit growth; EBITDA margin 27.25%-28.25%.
FY2024 guidance raised: low-single-digit revenue growth, EBITDA margin 26.25%-27.0% (increased from prior range).

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

EXPONENT INC reported first quarter of fiscal year 2024 ended March 29, 2024 results: revenue $144.9 million, net income $30.1 million, EPS $0.59 per diluted share. Guidance raised.

Period: first quarter of fiscal year 2024 ended March 29, 2024
Revenue: $144.9 million
Net income: $30.1 million
EPS: $0.59 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

Total revenues and revenues before reimbursements for the first quarter of 2024 increased 3.3% to $144.9 million and 6.6% to $137.2 million, respectively, as compared to $140.3 million and $128.7 million in the first quarter of 2023, respectively. Net income increased to $30.1 million, or $0.59 per diluted share, in the first quarter of 2024, as compared to $29.1 million, or $0.56 per diluted share, in the same period of 2023.

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

EXPONENT INC filing history →

Source: SEC EDGAR

accession 0001171843-24-002240

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.